HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	NIHR Health Technology Assessment programme	Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of monitoring of psychotherapeutic treatments: a randomized comparison on the effects of feedback to therapists and patients in three settings of outpatient psychotherapy]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Psychological treatment of personality disorders: a multi-centered randomised controlled trial on the (cost-)effectiveness of schema-focused therapy]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Validation of the 'Trimbos and iMTA questionnaire on costs associated with psychiatric illness' (TiC-P) for measuring health care utilisation and production loss]
2011	Health Council of the Netherlands Gezondheidsraad (GR)	[Population screening for cervical cancer]
2011	NIHR Health Technology Assessment programme	A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis and development of preventive activities in primary care. Review of the preferential offer and its support software (PAP)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Nurse-endoscopy of the colon; a randomized trial on accuracy, patient experiences and costs]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[A prospective, randomised controlled trial comparing in-hospital treatment and early assisted discharge for exacerbations of chronic obstructive pulmonary disease (COPD)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Quantifying COPD patients preferences for early assisted discharge and inpatient hospital care for COPD exacerbations: a discrete choice experiment]
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Antipsychotic polypharmacy in the treatment of schizophrenia]
2011	NIHR Health Technology Assessment programme	EVerT: cryotherapy versus salicylic acid for the treatment of verrucae - a randomised controlled trial
2011	The Swedish Council on Health Technology Assessment (SBU)	[Percutaneous vertebroplasty and balloon kyphoplasty in treating painful osteoporotic vertebral compression fractures]
2011	NIHR Health Technology Assessment programme	The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department
2011	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-a) inhibitors, adalimumab and infliximab, for Crohn's disease
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[A classification algorithm for low back pain: matching patients to treatments that they are most likely to benefit from]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[A randomised controlled trial comparing the cost-effectiveness of pelvic floor muscle exercise versus the TVT (O) procedure for female moderate to severe stress urinary incontinence]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[A randomized clinical trial of urinary incontinence in older women: cost-effectiveness of protocolized assessment and evidence-based treatment]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Assessment of Perinatal Outcome after Sustained Tocolysis for Early Labour (APOSTEL II)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Economic evaluation of joint replacement surgery alongside a multi-centre randomized trial in elderly patients with displaced femoral neck fractures]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Effects of a structured progressive task-oriented circuit training program to enhance walking competency after stroke (Acronym: FIT-STROKE Trial)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Group medical appointments for neuromuscular patients]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Primary G-CSF prophylaxis during the first two cycles only or throughout all chemotherapy cycles in breast cancer patients at risk of febrile neutropenia]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Rivastigmine for delirium in intensive care patients, a double-blind, randomised placebo-controlled add-on trial]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Surveillance after polypectomy - towards efficient guidelines]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The DExamethasone for Cardiac Surgery (DECS) trial: a large but simple trial to quantify the cost-effectiveness of dexamethasone in patients undergoing cardiac surgery]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The effects and costs of cranberry use to prevent clinical urinary tract infections in nursing home residents]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The efficacy of 'Radioguided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized controlled trial]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The long run - short run efficiency paradox in health care]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Transmural care for hand eczema; a randomised controlled trial and cost-effectiveness evaluation]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on borderline personality disorders]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2011	NIHR Health Technology Assessment programme	Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model
2011	Agency for Healthcare Research and Quality (AHRQ)	Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention
2011	Medical Advisory Secretariat (MAS)	Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011	NIHR Health Technology Assessment programme	An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health
2011	NIHR Health Technology Assessment programme	Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2011	NIHR Health Technology Assessment programme	Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Assessing the surgical skills of trainees in the operating theatre: a prospective observational study of the methodology
2011	NIHR Health Technology Assessment programme	Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer
2011	NIHR Health Technology Assessment programme	Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and costeffectiveness analysis
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review
2011	NIHR Health Technology Assessment programme	MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
2011	NIHR Health Technology Assessment programme	Growth monitoring for short stature: update of a systematic review and economic model
2011	NIHR Health Technology Assessment programme	Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
2011	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis
2011	NIHR Health Technology Assessment programme	Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: the DEPICTED study
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review
2011	NIHR Health Technology Assessment programme	Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
2011	NIHR Health Technology Assessment programme	Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection
2011	NIHR Health Technology Assessment programme	A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial
2011	NIHR Health Technology Assessment programme	Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation
2011	NIHR Health Technology Assessment programme	The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
2011	NIHR Health Technology Assessment programme	Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys
2011	NIHR Health Technology Assessment programme	A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
2011	NIHR Health Technology Assessment programme	Adaptive e-learning to improve dietary behaviour: a systematic review and cost-effectiveness analysis
2011	The Swedish Council on Health Technology Assessment (SBU)	[Bleeding peptic ulcer]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Benign Prostatic Obstruction (BPO)]
2011	NIHR Health Technology Assessment programme	An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Fibromyalgia and chronic fatigue syndrome: recommendations on diagnosis and treatment]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Assessment of bilateral cochlear implants in children. Indication criteria for cochlear implants in children and adults]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Positron emission tomography: proposal for prioritization of indications]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Efficiency in the use of operating surgical blocks. Definition of indicators]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a basic set of expert consensus-based quality indicators for the care delivered to stroke patients]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Total hip and knee artroplasties in Catalonia. Effectiveness and safety]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Everolimus (Afinitor) for the treatment of renal cell carcinoma]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Lapatinib (Tyverb) for the treatment of metastatic breast cancer]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Tolvaptan (Samsca) for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Enzymatic replacement treatment for type I gaucher's disease patients]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2011	Medical Advisory Secretariat (MAS)	Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis
2011	Medical Advisory Secretariat (MAS)	Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis
2011	HAYES, Inc.	Alport syndrome
2011	The Swedish Council on Health Technology Assessment (SBU)	[Analysis of fetal DNA in maternal blood: non-invasive fetal diagnostic tests for blood group and sex determination]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Computer-Aided Detection (CAD) in mammography screening]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Molecular diagnostic tests for men at higher probability for prostate cancer]
2011	Health Information and Quality Authority (HIQA)	A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011	Agency for Healthcare Research and Quality (AHRQ)	Evaluation of effectiveness and safety of antiepileptic medications in patients with epilepsy
2011	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and treatment of obstructive sleep apnea in adults
2011	Medical Services Advisory Committee (MSAC)	Measurement and determination of Procalcitonin (PCT)
2011	Health Intervention and Technology Assessment Program (HITAP)	[Designing a decision frame for making health resource allocation decisions: a case study in Thailand]
2011	Health Intervention and Technology Assessment Program (HITAP)	[Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2011	Health Intervention and Technology Assessment Program (HITAP)	Cost-utility analysis of adjuvant therapy for stage III colorectal cancer in Thailand]
2011	Health Intervention and Technology Assessment Program (HITAP)	[School-based screening for Attention Deficit and Hyperactivity Disorder (ADHD) and Learning Disorders (LD)]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Prevention of alcohol misuse among children, youths and young adults]